文献
J-GLOBAL ID:201802247403329715
整理番号:18A0511258
HCCの進行中のmiR 431を標的とするhsa_circ_0005075の新たな役割【Powered by NICT】
Emerging roles of hsa_circ_0005075 targeting miR-431 in the progress of HCC
著者 (27件):
Li Ming-fang
(School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China)
,
Li Ming-fang
(Institute for Liver Diseases, Anhui Medical University, ILD-AMU, Hefei 230032, China)
,
Li Ming-fang
(Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China)
,
Li Yu-huan
(School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China)
,
Li Yu-huan
(Institute for Liver Diseases, Anhui Medical University, ILD-AMU, Hefei 230032, China)
,
Li Yu-huan
(Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China)
,
He Ying-hua
(School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China)
,
He Ying-hua
(Institute for Liver Diseases, Anhui Medical University, ILD-AMU, Hefei 230032, China)
,
He Ying-hua
(Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China)
,
Wang Qin
(School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China)
,
Wang Qin
(Institute for Liver Diseases, Anhui Medical University, ILD-AMU, Hefei 230032, China)
,
Wang Qin
(Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China)
,
Zhang Ying
(School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China)
,
Zhang Ying
(Institute for Liver Diseases, Anhui Medical University, ILD-AMU, Hefei 230032, China)
,
Zhang Ying
(Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China)
,
Li Xiao-feng
(School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China)
,
Li Xiao-feng
(Institute for Liver Diseases, Anhui Medical University, ILD-AMU, Hefei 230032, China)
,
Li Xiao-feng
(Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China)
,
Meng Xiao-ming
(School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China)
,
Meng Xiao-ming
(Institute for Liver Diseases, Anhui Medical University, ILD-AMU, Hefei 230032, China)
,
Meng Xiao-ming
(Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China)
,
Huang Cheng
(School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China)
,
Huang Cheng
(Institute for Liver Diseases, Anhui Medical University, ILD-AMU, Hefei 230032, China)
,
Huang Cheng
(Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China)
,
Li Jun
(School of Pharmacy, Anhui Key Laboratory of Bioactivity of Natural Products, Anhui Medical University, Hefei 230032, China)
,
Li Jun
(Institute for Liver Diseases, Anhui Medical University, ILD-AMU, Hefei 230032, China)
,
Li Jun
(Anhui Institute of Innovative Drugs, Anhui Medical University, Hefei 230032, China)
資料名:
Biomedicine & Pharmacotherapy
(Biomedicine & Pharmacotherapy)
巻:
99
ページ:
848-858
発行年:
2018年
JST資料番号:
A0845C
ISSN:
0753-3322
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)